Literature DB >> 1386059

Human T cells expressing V beta 8 do not predominantly recognize DR2 alloantigen.

S E Christmas1, R Brew, I Crosby, I E Gecim, R A Sells.   

Abstract

A panel of seven monoclonal antibodies recognizing human T-cell antigen receptor (TcR) V alpha or V beta subsets has been used to measure TcR gene expression in peripheral blood lymphocytes and mixed lymphocyte culture responses (MLR) between DR2- and DR2+ (DRw15+) donors. There were no significant differences between DR2- and DR2+ donors in per cent T cells in fresh peripheral blood labelled with any of these antibodies, which included an antibody recognizing V beta 8. This indicates strongly that increased negative selection of V beta 8+ T cells does not occur in DR2+ compared with DR2- individuals. In MLR between DR2- and DR2+ donors the only significant change compared with fresh peripheral lymphocytes was that T cells expressing V beta 5.1 were decreased in DR2- lymphocyte populations responding to DR2 alloantigen. No changes in levels of V beta 8+ T cells were detected in MLR between DR2- and DR2+ donors. This suggests that V beta 8+ T cells are not predominantly reactive against DR2 (DRw15). The data support the concept that alloreactivity against a single class II major histocompatibility complex (MHC) mismatch is mediated by T cells expressing a range of different TcR V beta molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386059      PMCID: PMC1421540     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes.

Authors:  J Grunewald; C H Janson; H Wigzell
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

2.  Beta-chain gene rearrangements and V beta gene usage in DPw2-specific T cells.

Authors:  S S Beall; J V Lawrence; D A Bradley; D H Mattson; D S Singer; W E Biddison
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

Review 3.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

4.  Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy.

Authors:  C H Janson; M J Tehrani; H Mellstedt; H Wigzell
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Prevalence of antigen receptor variants in human T cell lines and tumors.

Authors:  H T Maecker; R Levy
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

6.  HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique.

Authors:  F Vartdal; G Gaudernack; S Funderud; A Bratlie; T Lea; J Ugelstad; E Thorsby
Journal:  Tissue Antigens       Date:  1986-11

7.  T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.

Authors:  P Marrack; J Kappler
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

8.  Preferential expression of V beta 6.7 domain on human peripheral CD4+ T cells. Implication for positive selection of T cells in man.

Authors:  A Cossarizza; M Kahan; C Ortolani; C Franceschi; M Londei
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

Review 9.  The thymus selects the useful, neglects the useless and destroys the harmful.

Authors:  H von Boehmer; H S Teh; P Kisielow
Journal:  Immunol Today       Date:  1989-02

10.  Idiotype-like molecules on cells of a human T cell leukemia.

Authors:  R D Bigler; D E Fisher; C Y Wang; E A Rinnooy Kan; H G Kunkel
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  1 in total

1.  Population study of T cell receptor V beta gene usage in peripheral blood lymphocytes: differences in ethnic groups.

Authors:  A Geursen; M A Skinner; L A Townsend; L K Perko; S J Farmiloe; J S Peake; I J Simpson; J D Fraser; P L Tan
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.